Biotech · Private company
Jubilant DraxImage Inc.
Track this companyFree. Adds Jubilant DraxImage Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 131-MIBG + VorinostatPhase 2 · NeuroblastomaClinicalTrials.gov · fetched Nov 12, 2026
- 131I-MIBGPhase 2 · NeuroblastomaClinicalTrials.gov · fetched Nov 12, 2026
- I-131 MIBGNeuroblastomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + DinutuximabPHASE2 · NOT_YET_RECRUITING · started Dec 31, 2026ClinicalTrials.gov NCT07261241 · fetched Nov 12, 2026
- A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma SubjectsPHASE2 · UNKNOWN · started Oct 21, 2019ClinicalTrials.gov NCT03561259 · fetched Nov 12, 2026
- Expanded Access Protocol Using 131I-MIBGAVAILABLEClinicalTrials.gov NCT01590680 · fetched Nov 12, 2026